Nucletron, ART partner for image-guided breast irradiation

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Nucletron, a radiation oncology company, and Advanced Radiation Therapy (ART) have signed an exclusive, global partnership to offer the AccuBoost system with the microSelectron high-dose rate (HDR) brachytherapy afterloader treatment delivery solution for the treatment of breast cancer. 

The partnership offers radiation oncology centers the opportunity to implement ART's technology in image-guided HDR breast brachytherapy on a pay-per-patient pricing model, along with Nucletron's treatment planning, treatment delivery, training, licensing, reimbursement and customized service support.

The Billerica, Mass.-based ART said its expansion of AccuBoost technology through its partnership with the Utrecht, Netherlands-based Nucletron will "reduce the barriers to adoption of brachytherapy for cancer centers previously deterred by the initial start-up costs usually associated with implementing a breast brachytherapy program."

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.